Pathologies

Antibiotics, by disturbing the intestinal microbiota, can cause more-or-less severe diarrhea.

Child malnutrition is not only due to a deficit or excess in dietary intake. The intestinal microbiota may also be involved.

Type 2 diabetes continues to increase throughout the world and hygiene/diet prevention measures aren’t enough. Modulating the intestinal microbiota may become a diagnostic and/or therapeutic tool.

Dyslipidemia is a common condition in the general population, which considerably increases cardiovascular risks. Treating it is essential, and modulating the intestinal microbiota may soon find its place in doctors’ therapeutic arsenal.

Enteral nutrition is associated with dysbiosis in the microbiota often causing diarrhea. Probiotics have proven effective for prevention.

Gingivitis is an inflammation of the gums whose persistence should raise concern about the risk of suffering a significantly more severe periodontal disease. It originates as the result of a change in the bacterial flora in dental plaque.

Rhinosinusitis is a chronic infection of the nasal and paranasal mucosa whose pathophysiological mechanisms are not fully understood yet. Studies on the role of the microbiota in its onset are being developed.

The presence of cardiovascular and metabolic risk factors, like elevated glycemia and cholesterol, hypertension, … is influenced by the composition of the intestinal microbiota.

Periodontal diseases are common and irreversible diseases that may eventually lead to loosening of teeth. Their onset is associated with an imbalance in the flora of the dental plaque.

Winter is prime season for respiratory infections, which take advantage of a weakened immune system. Probiotics and synbiotics may be added to the prevention strategy and existing therapy.

Chronic inflammatory bowel diseases (IBDs), like Crohn’s disease and ulcerative colitis, are correlated with an imbalance in the microbiota.

Strengthening intestinal microbiota: a prophylactic treatment for traveler’s diarrhea? Some studies suggest that it is possible, but more research still needs to be done.

Gastrointestinal cancers have many possible causes. Although genetics and environment have a clear impact, the influence of gastric microbiota has been studied extensively.

Celiac disease is a disease with many unknowns. A new field of explanations has been opened with evidence suggesting that celiac patients present a dysbiosis in the intestinal microbiota, which promotes the pro-inflammatory role of gluten.

The intestinal equilibrium is significantly affected in cases of infectious diarrhea. Studying the microbial ecosystem over the course of the infection has resulted in notable progress in the treatment of this disorder.

Short bowel syndrome (SBS) is a state of intestinal malabsorption following resection. The remaining colon and its microbiota play a decisive role in how the intestine adapts after resection.

Antibiotics, by disturbing the intestinal microbiota, can cause more-or-less severe diarrhea.

Child malnutrition is not only due to a deficit or excess in dietary intake. The intestinal microbiota may also be involved.

Type 2 diabetes continues to increase throughout the world and hygiene/diet prevention measures aren’t enough. Modulating the intestinal microbiota may become a diagnostic and/or therapeutic tool.

Dyslipidemia is a common condition in the general population, which considerably increases cardiovascular risks. Treating it is essential, and modulating the intestinal microbiota may soon find its place in doctors’ therapeutic arsenal.

Enteral nutrition is associated with dysbiosis in the microbiota often causing diarrhea. Probiotics have proven effective for prevention.

Gingivitis is an inflammation of the gums whose persistence should raise concern about the risk of suffering a significantly more severe periodontal disease. It originates as the result of a change in the bacterial flora in dental plaque.

Rhinosinusitis is a chronic infection of the nasal and paranasal mucosa whose pathophysiological mechanisms are not fully understood yet. Studies on the role of the microbiota in its onset are being developed.

The presence of cardiovascular and metabolic risk factors, like elevated glycemia and cholesterol, hypertension, … is influenced by the composition of the intestinal microbiota.

Periodontal diseases are common and irreversible diseases that may eventually lead to loosening of teeth. Their onset is associated with an imbalance in the flora of the dental plaque.

Winter is prime season for respiratory infections, which take advantage of a weakened immune system. Probiotics and synbiotics may be added to the prevention strategy and existing therapy.

Chronic inflammatory bowel diseases (IBDs), like Crohn’s disease and ulcerative colitis, are correlated with an imbalance in the microbiota.

Strengthening intestinal microbiota: a prophylactic treatment for traveler’s diarrhea? Some studies suggest that it is possible, but more research still needs to be done.

Gastrointestinal cancers have many possible causes. Although genetics and environment have a clear impact, the influence of gastric microbiota has been studied extensively.

Celiac disease is a disease with many unknowns. A new field of explanations has been opened with evidence suggesting that celiac patients present a dysbiosis in the intestinal microbiota, which promotes the pro-inflammatory role of gluten.

The intestinal equilibrium is significantly affected in cases of infectious diarrhea. Studying the microbial ecosystem over the course of the infection has resulted in notable progress in the treatment of this disorder.

Short bowel syndrome (SBS) is a state of intestinal malabsorption following resection. The remaining colon and its microbiota play a decisive role in how the intestine adapts after resection.

Antibiotics, by disturbing the intestinal microbiota, can cause more-or-less severe diarrhea.

Child malnutrition is not only due to a deficit or excess in dietary intake. The intestinal microbiota may also be involved.

Type 2 diabetes continues to increase throughout the world and hygiene/diet prevention measures aren’t enough. Modulating the intestinal microbiota may become a diagnostic and/or therapeutic tool.

Dyslipidemia is a common condition in the general population, which considerably increases cardiovascular risks. Treating it is essential, and modulating the intestinal microbiota may soon find its place in doctors’ therapeutic arsenal.

Enteral nutrition is associated with dysbiosis in the microbiota often causing diarrhea. Probiotics have proven effective for prevention.

Gingivitis is an inflammation of the gums whose persistence should raise concern about the risk of suffering a significantly more severe periodontal disease. It originates as the result of a change in the bacterial flora in dental plaque.

Rhinosinusitis is a chronic infection of the nasal and paranasal mucosa whose pathophysiological mechanisms are not fully understood yet. Studies on the role of the microbiota in its onset are being developed.

The presence of cardiovascular and metabolic risk factors, like elevated glycemia and cholesterol, hypertension, … is influenced by the composition of the intestinal microbiota.

Periodontal diseases are common and irreversible diseases that may eventually lead to loosening of teeth. Their onset is associated with an imbalance in the flora of the dental plaque.

Winter is prime season for respiratory infections, which take advantage of a weakened immune system. Probiotics and synbiotics may be added to the prevention strategy and existing therapy.

Chronic inflammatory bowel diseases (IBDs), like Crohn’s disease and ulcerative colitis, are correlated with an imbalance in the microbiota.

Strengthening intestinal microbiota: a prophylactic treatment for traveler’s diarrhea? Some studies suggest that it is possible, but more research still needs to be done.

Gastrointestinal cancers have many possible causes. Although genetics and environment have a clear impact, the influence of gastric microbiota has been studied extensively.

Celiac disease is a disease with many unknowns. A new field of explanations has been opened with evidence suggesting that celiac patients present a dysbiosis in the intestinal microbiota, which promotes the pro-inflammatory role of gluten.

The intestinal equilibrium is significantly affected in cases of infectious diarrhea. Studying the microbial ecosystem over the course of the infection has resulted in notable progress in the treatment of this disorder.

Short bowel syndrome (SBS) is a state of intestinal malabsorption following resection. The remaining colon and its microbiota play a decisive role in how the intestine adapts after resection.

Antibiotics, by disturbing the intestinal microbiota, can cause more-or-less severe diarrhea.

Child malnutrition is not only due to a deficit or excess in dietary intake. The intestinal microbiota may also be involved.

Type 2 diabetes continues to increase throughout the world and hygiene/diet prevention measures aren’t enough. Modulating the intestinal microbiota may become a diagnostic and/or therapeutic tool.

Dyslipidemia is a common condition in the general population, which considerably increases cardiovascular risks. Treating it is essential, and modulating the intestinal microbiota may soon find its place in doctors’ therapeutic arsenal.

Enteral nutrition is associated with dysbiosis in the microbiota often causing diarrhea. Probiotics have proven effective for prevention.

Gingivitis is an inflammation of the gums whose persistence should raise concern about the risk of suffering a significantly more severe periodontal disease. It originates as the result of a change in the bacterial flora in dental plaque.

Rhinosinusitis is a chronic infection of the nasal and paranasal mucosa whose pathophysiological mechanisms are not fully understood yet. Studies on the role of the microbiota in its onset are being developed.

The presence of cardiovascular and metabolic risk factors, like elevated glycemia and cholesterol, hypertension, … is influenced by the composition of the intestinal microbiota.

Periodontal diseases are common and irreversible diseases that may eventually lead to loosening of teeth. Their onset is associated with an imbalance in the flora of the dental plaque.

Winter is prime season for respiratory infections, which take advantage of a weakened immune system. Probiotics and synbiotics may be added to the prevention strategy and existing therapy.

Chronic inflammatory bowel diseases (IBDs), like Crohn’s disease and ulcerative colitis, are correlated with an imbalance in the microbiota.

Strengthening intestinal microbiota: a prophylactic treatment for traveler’s diarrhea? Some studies suggest that it is possible, but more research still needs to be done.

Gastrointestinal cancers have many possible causes. Although genetics and environment have a clear impact, the influence of gastric microbiota has been studied extensively.

Celiac disease is a disease with many unknowns. A new field of explanations has been opened with evidence suggesting that celiac patients present a dysbiosis in the intestinal microbiota, which promotes the pro-inflammatory role of gluten.

The intestinal equilibrium is significantly affected in cases of infectious diarrhea. Studying the microbial ecosystem over the course of the infection has resulted in notable progress in the treatment of this disorder.

Short bowel syndrome (SBS) is a state of intestinal malabsorption following resection. The remaining colon and its microbiota play a decisive role in how the intestine adapts after resection.